US Patent 11407775 Compositions and methods for phosphoramidite and oligonucleotide synthesis

Is a

Patent

Patent attributes

Patent Applicant

Wave Life Sciences

Current Assignee

Wave Life Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

114077750

Patent Inventor Names

David Charles Donnell Butler0

Subramanian Marappan0

Ik-Hyeon Paik0

Date of Patent

August 9, 2022

Patent Application Number

160845560

Date Filed

March 13, 2017

Patent Citations

‌

US Patent 10149905 Chiral nucleic acid adjuvant having antitumor effect and antitumor agent

‌

US Patent 10160969 Chiral design

‌

US Patent 10167309 Asymmetric auxiliary group

‌

US Patent 10280192 Methods for the synthesis of functionalized nucleic acids

‌

US Patent 10307434 Nucleic acid prodrugs and methods of use thereof

‌

US Patent 10322173 Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent

‌

US Patent 10329318 Method for the synthesis of phosphorus atom modified nucleic acids

‌

US Patent 10428019 Chiral auxiliaries

...

Patent Citations Received

‌

US Patent 11873316 Compositions and methods for phosphoramidite and oligonucleotide synthesis

‌

US Patent 11608355 Technologies for oligonucleotide preparation

Patent Primary Examiner

CPC Code

The present disclosure, among other things, provides technologies for preparing and purifying phosphoramidites for oligonucleotide synthesis.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11407775 Compositions and methods for phosphoramidite and oligonucleotide synthesis

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11407775 Compositions and methods for phosphoramidite and oligonucleotide synthesis